Biocept Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
69.20
5,364.60
8,821.30
4,609.30
2,146.60
3,423.40
Total Accounts Receivable
9.20
10.60
34.20
129.00
1,193.40
1,574.30
Inventories
92.80
188.70
349.30
549.00
498.70
587.20
Other Current Assets
799.10
338.70
435.90
484.60
416.60
426
Total Current Assets
970.30
5,902.60
9,640.70
5,772.00
4,255.30
6,010.90
Net Property, Plant & Equipment
358.90
662.40
946.20
1,806.30
3,123.60
2,739.40
Other Assets
0.50
23.20
-
-
-
-
Total Assets
1,329.70
6,588.20
10,586.90
7,578.30
7,378.90
8,750.30
ST Debt & Current Portion LT Debt
7,400.50
89.50
1,741.40
2,273.00
1,639.00
Accounts Payable
1,540.60
641.40
632.50
960.50
1,270.00
Other Current Liabilities
4,382.60
699.90
966.90
1,160.00
1,752.40
Total Current Liabilities
13,323.70
1,430.80
3,340.80
4,393.60
4,661.30
Long-Term Debt
-
4,823.30
2,929.70
1,901.60
1,150.10
Other Liabilities
462.00
554.70
623.70
624.50
271.50
Total Liabilities
13,785.70
6,808.80
6,894.20
6,919.70
6,082.90
Common Equity (Total)
12,463.00
220.60
3,692.70
658.70
1,296.00
Total Shareholders' Equity
12,456.00
220.60
3,692.70
658.70
1,296.00
Total Equity
12,456.00
220.60
3,692.70
658.70
1,296.00
Liabilities & Shareholders' Equity
1,329.70
6,588.20
10,586.90
7,578.30
7,378.90
Preferred Stock (Carrying Value)
6.90
-
-
-
-

About Biocept

View Profile
Address
5810 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.biocept.com
Updated 07/08/2019
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests.